Hakutulokset - Mertens, Daniel

Biological diversity and risk-adapted treatment of chronic lymphocytic leukemia Tekijä Zenz, Thorsten, Mertens, Daniel, Stilgenbauer, Stephan

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Chronic lymphocytic leukemia – genomics lead the way Tekijä Mertens, Daniel, Bullinger, Lars, Stilgenbauer, Stephan

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Advances in treating chronic lymphocytic leukemia Tekijä Tausch, Eugen, Mertens, Daniel, Stilgenbauer, Stephan

Hae kokoteksti Hae kokoteksti Hae kokoteksti

From Biology to Therapy: The CLL Success Story Tekijä Yosifov, Deyan Y., Wolf, Christine, Stilgenbauer, Stephan, Mertens, Daniel

Hae kokoteksti Hae kokoteksti Hae kokoteksti

DNA methylation of chronic lymphocytic leukemia with differential response to chemotherapy Tekijä Yosifov, Deyan Yordanov, Bloehdorn, Johannes, Döhner, Hartmut, Lichter, Peter, Stilgenbauer, Stephan, Mertens, Daniel

Hae kokoteksti Hae kokoteksti Hae kokoteksti

TCL1A and ATM are co-expressed in chronic lymphocytic leukemia cells without deletion of 11q Tekijä Garding, Angela, Bhattacharya, Nupur, Haebe, Sarah, Müller, Frederike, Weichenhan, Dieter, Idler, Irina, Ickstadt, Katja, Stilgenbauer, Stephan, Mertens, Daniel

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Venetoclax resistance and acquired BCL2 mutations in chronic lymphocytic leukemia Tekijä Tausch, Eugen, Close, William, Dolnik, Anna, Bloehdorn, Johannes, Chyla, Brenda, Bullinger, Lars, Döhner, Hartmut, Mertens, Daniel, Stilgenbauer, Stephan

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Off-target effects of siRNA specific for GFP Tekijä Tschuch, Cordula, Schulz, Angela, Pscherer, Armin, Werft, Wiebke, Benner, Axel, Hotz-Wagenblatt, Agnes, Barrionuevo, Leticia Serra, Lichter, Peter, Mertens, Daniel

Hae kokoteksti Hae kokoteksti Hae kokoteksti

The Phospholipase Cγ(2) Mutants R665W and L845F Identified in Ibrutinib-resistant Chronic Lymphocytic Leukemia Patients Are Hypersensitive to the Rho GTPase Rac2 Protein Tekijä Walliser, Claudia, Hermkes, Elisabeth, Schade, Anja, Wiese, Sebastian, Deinzer, Julia, Zapatka, Marc, Désiré, Laurent, Mertens, Daniel, Stilgenbauer, Stephan, Gierschik, Peter

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Programmed Death-1 and Its Ligand Are Novel Immunotolerant Molecules Expressed on Leukemic B Cells in Chronic Lymphocytic Leukemia Tekijä Grzywnowicz, Maciej, Zaleska, Joanna, Mertens, Daniel, Tomczak, Waldemar, Wlasiuk, Paulina, Kosior, Kamila, Piechnik, Agnieszka, Bojarska-Junak, Agnieszka, Dmoszynska, Anna, Giannopoulos, Krzysztof

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Allelic silencing at the tumor-suppressor locus 13q14.3 suggests an epigenetic tumor-suppressor mechanism Tekijä Mertens, Daniel, Wolf, Stephan, Tschuch, Cordula, Mund, Cora, Kienle, Dirk, Ohl, Sibylle, Schroeter, Petra, Lyko, Frank, Döhner, Hartmut, Stilgenbauer, Stephan, Lichter, Peter

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Krüppel-like factor 4 (KLF4) inactivation in chronic lymphocytic leukemia correlates with promoter DNA-methylation and can be reversed by inhibition of NOTCH signaling Tekijä Filarsky, Katharina, Garding, Angela, Becker, Natalia, Wolf, Christine, Zucknick, Manuela, Claus, Rainer, Weichenhan, Dieter, Plass, Christoph, Döhner, Hartmut, Stilgenbauer, Stephan, Lichter, Peter, Mertens, Daniel

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapy Tekijä Zapatka, Marc, Tausch, Eugen, Öztürk, Selcen, Yosifov, Deyan Yordanov, Seiffert, Martina, Zenz, Thorsten, Schneider, Christof, Bloehdorn, Johannes, Döhner, Hartmut, Mertens, Daniel, Lichter, Peter, Stilgenbauer, Stephan

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Germline Allele-Specific Expression of DAPK1 in Chronic Lymphocytic Leukemia Tekijä Wei, Quan-Xiang, Claus, Rainer, Hielscher, Thomas, Mertens, Daniel, Raval, Aparna, Oakes, Christopher C., Tanner, Stephan M., de la Chapelle, Albert, Byrd, John C., Stilgenbauer, Stephan, Plass, Christoph

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Hydroxylation of the NOTCH1 intracellular domain regulates Notch signaling dynamics Tekijä Ferrante, Francesca, Giaimo, Benedetto Daniele, Friedrich, Tobias, Sugino, Toshiya, Mertens, Daniel, Kugler, Sabrina, Gahr, Bernd Martin, Just, Steffen, Pan, Leiling, Bartkuhn, Marek, Potente, Michael, Oswald, Franz, Borggrefe, Tilman

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Protein expression analysis of chronic lymphocytic leukemia defines the effect of genetic aberrations and uncovers a correlation of CDK4, P27 and P53 with hierarchical risk Tekijä Winkler, Dirk, Schneider, Christof, Zucknick, Manuela, Bögelein, Daniela, Schulze, Kerstin, Zenz, Thorsten, Mohr, Julia, Philippen, Angela, Huber, Henriette, Bühler, Andreas, Habermann, Annett, Benner, Axel, Döhner, Hartmut, Stilgenbauer, Stephan, Mertens, Daniel

Hae kokoteksti Hae kokoteksti Hae kokoteksti

HDAC3 functions as a positive regulator in Notch signal transduction Tekijä Ferrante, Francesca, Giaimo, Benedetto Daniele, Bartkuhn, Marek, Zimmermann, Tobias, Close, Viola, Mertens, Daniel, Nist, Andrea, Stiewe, Thorsten, Meier-Soelch, Johanna, Kracht, Michael, Just, Steffen, Klöble, Patricia, Oswald, Franz, Borggrefe, Tilman

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Matrix-Dependent Regulation of AKT in Hepsin-Overexpressing PC3 Prostate Cancer Cells Tekijä Wittig-Blaich, Stephanie M, Kacprzyk, Lukasz A, Eismann, Thorsten, Bewerunge-Hudler, Melanie, Kruse, Petra, Winkler, Eva, Strauss, Wolfgang S L, Hibst, Raimund, Steiner, Rudolf, Schrader, Mark, Mertens, Daniel, Sültmann, Holger, Wittig, Rainer

Hae kokoteksti Hae kokoteksti

CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling Tekijä Faber, Katrin, Bullinger, Lars, Ragu, Christine, Garding, Angela, Mertens, Daniel, Miller, Christina, Martin, Daniela, Walcher, Daniel, Döhner, Konstanze, Döhner, Hartmut, Claus, Rainer, Plass, Christoph, Sykes, Stephen M., Lane, Steven W., Scholl, Claudia, Fröhling, Stefan

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patients Tekijä Bloehdorn, Johannes, Krzykalla, Julia, Holzmann, Karlheinz, Gerhardinger, Andreas, Jebaraj, Billy Michael Chelliah, Bahlo, Jasmin, Humphrey, Kathryn, Tausch, Eugen, Robrecht, Sandra, Mertens, Daniel, Schneider, Christof, Fischer, Kirsten, Hallek, Michael, Döhner, Hartmut, Benner, Axel, Stilgenbauer, Stephan

Hae kokoteksti Hae kokoteksti Hae kokoteksti